| ANETArista Networks, Inc. |
$9B |
39.0% |
2025 |
| ARLOArlo Technologies, Inc. |
$529.3M |
2.8% |
2025 |
| ARMPArmata Pharmaceuticals, Inc. |
n/a |
n/a |
2025 |
| ARRArmour Residential REIT, Inc. |
n/a |
n/a |
2025 |
| ARQArq, Inc. |
$120.3M |
-43.7% |
2025 |
| ARQQArqit Quantum Inc. |
$293K |
-18,628.3% |
2024 |
| ARRYArray Technologies, Inc. |
$1.3B |
-4.1% |
2025 |
| AVBPArriVent BioPharma, Inc. |
n/a |
n/a |
2025 |
| BANXArrowMark Financial Corp. |
n/a |
n/a |
n/a |
| AIPArteris, Inc. |
$70.6M |
-49.2% |
2025 |
| AJGArthur J. Gallagher & Co. |
$13.9B |
10.7% |
2025 |
| APAMArtisan Partners Asset Management Inc. |
$1.2B |
24.3% |
2025 |
| ARTVArtiva Biotherapeutics, Inc. |
$0 |
n/a |
2025 |
| ARXSArxis, Inc. |
n/a |
n/a |
n/a |
| ASANAsana, Inc. |
$790.8M |
-23.9% |
2026 |
| ASNDAscendis Pharma A/S |
€720.1M |
-31.7% |
2025 |
| SORAAsiaStrategy |
$11M |
111.9% |
2025 |
| ALABAstera Labs, Inc. |
$852.5M |
25.7% |
2025 |
| ASTHAstrana Health, Inc. |
$3.2B |
0.7% |
2025 |
| ALOTAstroNova, Inc. |
$150.5M |
-1.6% |
2026 |
| ATAIAtaiBeckley Inc. |
$4.1M |
-16,142.0% |
2025 |
| ATRAAtara Biotherapeutics, Inc. |
$120.8M |
27.1% |
2025 |
| AVIRAtea Pharmaceuticals, Inc. |
n/a |
n/a |
2025 |
| ASICAtegrity Specialty Insurance Co Holdings |
$424.3M |
17.4% |
2025 |
| ATHSAthene Holding Ltd. |
$25.7B |
10.6% |
2025 |
| ATKRAtkore Inc. |
$2.9B |
-0.5% |
2025 |
| AUBAtlantic Union Bankshares Corp |
n/a |
n/a |
2025 |
| ATLCAtlanticus Holdings Corp |
$2B |
6.2% |
2025 |
| AESIAtlas Energy Solutions Inc. |
$1.1B |
-4.6% |
2025 |
| ATLXAtlas Lithium Corp |
$121.4K |
-23,157.6% |
2025 |
| TEAMAtlassian Corp |
$6.6B |
-0.8% |
2026 |
| ATMUAtmus Filtration Technologies Inc. |
$1.8B |
11.8% |
2025 |
| ATOMAtomera Inc |
$65K |
-31,036.9% |
2025 |
| ATATAtour Lifestyle Holdings Ltd |
$1.4B |
16.6% |
2025 |
| ATRCAtriCure, Inc. |
$534.5M |
-2.1% |
2025 |
| RNAAtrium Therapeutics, Inc. |
n/a |
n/a |
n/a |
| ATTOAttovia Therapeutics, Inc. |
n/a |
n/a |
n/a |
| AURAAura Biosciences, Inc. |
n/a |
n/a |
2025 |
| AUGOAura Minerals Inc. |
n/a |
n/a |
n/a |
| AUREAurelion Inc. |
$639.9K |
-1,074.7% |
2024 |
| PUSAAureus Greenway Holdings Inc |
$3M |
-124.0% |
2025 |
| AUPHAurinia Pharmaceuticals Inc. |
$283.1M |
101.5% |
2025 |
| AURAurora Innovation, Inc. |
$3M |
-27,200.0% |
2025 |
| ADSKAutodesk, Inc. |
$7.2B |
15.6% |
2026 |
| ATHMAutohome Inc. |
$922.6M |
22.4% |
2025 |
| AUTLAutolus Therapeutics plc |
$75.4M |
-381.4% |
2025 |
| AVTXAvalo Therapeutics, Inc. |
$59K |
-132,642.4% |
2025 |
| AVLNAvalyn Pharma Inc. |
n/a |
n/a |
n/a |
| AVTRAvantor, Inc. |
$6.6B |
-8.1% |
2025 |
| AVPTAvePoint, Inc. |
$419.5M |
8.3% |
2025 |